Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40


Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.

Rabe KF, Fabbri LM, Israel E, Kögler H, Riemann K, Schmidt H, Glaab T, Vogelmeier CF.

Lancet Respir Med. 2014 Jan;2(1):44-53. doi: 10.1016/S2213-2600(13)70248-0. Epub 2013 Dec 5.


Effects of dipeptidyl peptidase-4 inhibition in an animal model of experimental asthma: a matter of dose, route, and time.

Stephan M, Suhling H, Schade J, Wittlake M, Tasic T, Klemann C, Pabst R, Jurawitz MC, Raber KA, Hoymann HG, Braun A, Glaab T, Hoffmann T, Schmiedl A, von Hörsten S.

Physiol Rep. 2013 Oct;1(5):e00095. doi: 10.1002/phy2.95. Epub 2013 Oct 2.


Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial.

Beeh KM, Glaab T, Stowasser S, Schmidt H, Fabbri LM, Rabe KF, Vogelmeier CF.

Respir Res. 2013 Oct 29;14:116. doi: 10.1186/1465-9921-14-116.


Seasonal distribution of COPD exacerbations in the Prevention of Exacerbations with Tiotropium in COPD trial.

Rabe KF, Fabbri LM, Vogelmeier C, Kögler H, Schmidt H, Beeh KM, Glaab T.

Chest. 2013 Mar;143(3):711-9.


[Use of a lung function screening device for identifying patients at risk for COPD in general practice].

Müller M, Kögler H, Glaab T, Welte T.

Pneumologie. 2012 Nov;66(11):645-9. doi: 10.1055/s-0032-1325791. Epub 2012 Nov 6. German.


Effect of tiotropium vs. salmeterol on exacerbations: GOLD II and maintenance therapy naïve patients.

Vogelmeier C, Fabbri LM, Rabe KF, Beeh KM, Schmidt H, Metzdorf N, Glaab T.

Respir Med. 2013 Jan;107(1):75-83. doi: 10.1016/j.rmed.2012.09.015. Epub 2012 Oct 26.


[Early treatment of COPD with tiotropium].

Buhl R, Welte T, Vogelmeier C, Gillissen A, Voshaar T, Kögler H, Liu D, Glaab T.

Pneumologie. 2012 Oct;66(10):589-95. doi: 10.1055/s-0032-1310281. Epub 2012 Sep 25. German.


Detection of air trapping in chronic obstructive pulmonary disease by low frequency ultrasound.

Morenz K, Biller H, Wolfram F, Leonhadt S, Rüter D, Glaab T, Uhlig S, Hohlfeld JM.

BMC Pulm Med. 2012 Mar 16;12:8. doi: 10.1186/1471-2466-12-8.


Guideline-based survey of outpatient COPD management by pulmonary specialists in Germany.

Glaab T, Vogelmeier C, Hellmann A, Buhl R.

Int J Chron Obstruct Pulmon Dis. 2012;7:101-8. doi: 10.2147/COPD.S27887. Epub 2012 Feb 14.


In vitro validation of a Respimat® adapter for delivery of inhaled bronchodilators during mechanical ventilation.

Dellweg D, Wachtel H, Höhn E, Pieper MP, Barchfeld T, Köhler D, Glaab T.

J Aerosol Med Pulm Drug Deliv. 2011 Dec;24(6):285-92. doi: 10.1089/jamp.2011.0883. Epub 2011 Aug 26.


A practical guide to bioelectrical impedance analysis using the example of chronic obstructive pulmonary disease.

Walter-Kroker A, Kroker A, Mattiucci-Guehlke M, Glaab T.

Nutr J. 2011 Apr 21;10:35. doi: 10.1186/1475-2891-10-35. Review.


Tiotropium versus salmeterol for the prevention of exacerbations of COPD.

Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Mölken MP, Beeh KM, Rabe KF, Fabbri LM; POET-COPD Investigators.

N Engl J Med. 2011 Mar 24;364(12):1093-1103. doi: 10.1056/NEJMoa1008378.


Tiotropium Respimat® improves physical functioning in chronic obstructive pulmonary disease.

Rau-Berger H, Mitfessel H, Glaab T.

Int J Chron Obstruct Pulmon Dis. 2010 Oct 10;5:367-73.


Effects of inhaled corticosteroids in stable chronic obstructive pulmonary disease.

Glaab T, Taube C.

Pulm Pharmacol Ther. 2011 Feb;24(1):15-22. doi: 10.1016/j.pupt.2010.08.006. Epub 2010 Sep 8. Review.


Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations.

Glaab T, Vogelmeier C, Buhl R.

Respir Res. 2010 Jun 17;11:79. doi: 10.1186/1465-9921-11-79. Review.


Reduced airway inflammation in CD26/DPP4-deficient F344 rats is associated with altered recruitment patterns of regulatory T cells and expression of pulmonary surfactant proteins.

Schmiedl A, Krainski J, Schwichtenhövel F, Schade J, Klemann C, Raber KA, Zscheppang K, Beekmann T, Acevedo C, Glaab T, Wedekind D, Pabst R, von Hörsten S, Stephan M.

Clin Exp Allergy. 2010 Dec;40(12):1794-808. doi: 10.1111/j.1365-2222.2010.03547.x.


Statistical analysis of chronic obstructive pulmonary disease exacerbations in clinical studies: expectations and limitations.

Gillissen A, Glaab T, Lewis M, Buhl R, Worth H.

J Physiol Pharmacol. 2009 Nov;60 Suppl 5:7-11. Review.


Preselection of patients at risk for COPD by two simple screening questions.

Kögler H, Metzdorf N, Glaab T, Welte T.

Respir Med. 2010 Jul;104(7):1012-9. doi: 10.1016/j.rmed.2010.01.005.


Is there a role for antiinflammatory treatment in COPD?

Beeh KM, Glaab T.

COPD. 2009 Oct;6(5):395-403. Review.


Study design considerations in a large COPD trial comparing effects of tiotropium with salmeterol on exacerbations.

Beeh KM, Hederer B, Glaab T, Müller A, Rutten-van Moelken M, Kesten S, Vogelmeier C.

Int J Chron Obstruct Pulmon Dis. 2009;4:119-25. Epub 2009 Apr 15.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk